170 related articles for article (PubMed ID: 9641482)
1. Baroreflex-mediated bradycardia is blunted by intravenous mu- but not kappa-opioid agonists.
Omoniyi AT; Wu D; Soong Y; Szeto HH
J Cardiovasc Pharmacol; 1998 Jun; 31(6):954-9. PubMed ID: 9641482
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
3. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
[TBL] [Abstract][Full Text] [Related]
4. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
[TBL] [Abstract][Full Text] [Related]
5. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
6. A peripheral site of action for the attenuation of baroflex-mediated bradycardia by intravenous mu-opioid agonists.
Omoniyi AT; Kett A; Wu D; Soong Y; Clapp JF; Szeto HH
J Cardiovasc Pharmacol; 2000 Feb; 35(2):269-74. PubMed ID: 10672860
[TBL] [Abstract][Full Text] [Related]
7. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
[TBL] [Abstract][Full Text] [Related]
8. Effects of mu-, delta- and kappa-agonists on isolated right atria of the rat.
Micol JA; Laorden ML
Neuropeptides; 1994 Jun; 26(6):365-70. PubMed ID: 7936123
[TBL] [Abstract][Full Text] [Related]
9. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
10. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T
Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150
[TBL] [Abstract][Full Text] [Related]
12. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
[TBL] [Abstract][Full Text] [Related]
13. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
Müller W; Hallermann S; Swandulla D
J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
[TBL] [Abstract][Full Text] [Related]
14. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
15. Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test.
Motta V; Penha K; Brandão ML
Psychopharmacology (Berl); 1995 Aug; 120(4):470-4. PubMed ID: 8539329
[TBL] [Abstract][Full Text] [Related]
16. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
Werling LL; McMahon PN; Cox BM
J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
[TBL] [Abstract][Full Text] [Related]
17. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles.
Martin TJ; Sexton T; Kim SA; Severino AL; Peters CM; Young LJ; Childers SR
Neuroscience; 2015 Dec; 311():422-9. PubMed ID: 26523979
[TBL] [Abstract][Full Text] [Related]
19. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
20. U50,488H-induced pressor effect in the ovine foetus is mediated by sympathetic activation and vasopressin.
Szeto HH; Wu D; Yee JS; Soong Y; Fukuda S; Taylor CT
Eur J Pharmacol; 1996 Aug; 309(2):183-7. PubMed ID: 8874137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
